Randomized, Blinded, Placebo-controlled Crossover Study Assessing Association Between Gadolinium-based Contrast Agent Administration and Transient Dyspnea/Arterial Phase Motion Artifact
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Gadoxetate disodium (Primary) ; Gadoterate-meglumine
- Indications Respiratory insufficiency
- Focus Therapeutic Use
- 03 Sep 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 22 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 May 2015 New trial record